Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK

Showing 12 out of 2518 results
That Cancer Conversation in a white speech bubble with a dark blue background

Is the future of cancer detection in our blood? Our latest podcast episode looks into liquid biopsies, tests that use tumour DNA to help find, track and treat cancer. Professor Nitzan Rosenfeld, a liquid biopsy pioneer, shares all the details. Is the future of cancer detection in our blood? Our latest podcast episode looks into liquid biopsies, tests that use tumour DNA to help find, track and treat cancer. Professor Nitzan Rosenfeld, a liquid biopsy pioneer, shares all the details.

by Cancer Research UK | Podcast | 19 February 2026

19 February 2026

This entry is part 34 of 34 in the series That Cancer Conversation
Extracellular matrix
  • For Researchers

Surviving in the matrix

The extracellular matrix is much more than just a passive supporting environment for cells… so does it have a role in cancer? The extracellular matrix is much more than just a passive supporting environment for cells… so does it have a role in cancer?

by Cancer Research UK | In depth | 17 February 2026

17 February 2026

Careers

Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it... Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it...

by Cancer Research UK | Analysis | 11 February 2026

11 February 2026

This entry is part 8 of 8 in the series Research Careers
This entry is part 33 of 34 in the series That Cancer Conversation
That Cancer Conversation in a white speech bubble with a dark blue background

In this episode we discuss how AI is starting to shape healthcare. We speak to technology broadcaster and journalist, Lara Lewington and AI researcher, Prof Peter Coveney. In this episode we discuss how AI is starting to shape healthcare. We speak to technology broadcaster and journalist, Lara Lewington and AI researcher, Prof Peter Coveney.

by Cancer Research UK | Podcast | 22 January 2026

22 January 2026

This entry is part 32 of 34 in the series That Cancer Conversation
Patient involvement

Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways... Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways...

by Cancer Research UK | In depth | 15 January 2026

15 January 2026

This entry is part 31 of 34 in the series That Cancer Conversation
Adeno-associated Virus,

Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic... Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic...

by Cancer Research UK | In depth | 6 January 2026

6 January 2026

The Cancer Research UK team outside the Senedd.

A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion. A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion.

by Cancer Research UK | Analysis | 10 December 2025

10 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025